Personal information

No personal information available

Activities

Collapse all

Employment (1)

National Institutes of Health: Bethesda, Maryland, US

2018-02-19 to present | Post-doctoral Fellow (National Cancer Institute)
Employment
Source: Self-asserted source
Yo-Ting Tsai

Education and qualifications (1)

The Ohio State University: Columbus, Ohio, US

2012-06 to 2017-08 | Ph.D.
Education
Source: Self-asserted source
Yo-Ting Tsai

Works (5)

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer
2024-03 | Journal article
DOI: 10.1136/jitc-2023-008480
Contributors: Arun Rajan; Houssein Abdul Sater; Osama Rahma; Richy Agajanian; Wiem Lassoued; Jennifer L Marté; Yo-Ting Tsai; Renee N Donahue; Elizabeth Lamping; Shania Bailey et al.
Source: check_circle
Crossref

Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade

Journal of Experimental & Clinical Cancer Research
2024-03-16 | Journal article
DOI: 10.1186/s13046-024-02969-1
Contributors: Yo-Ting Tsai; Jeffrey Schlom; Renee N. Donahue
Source: check_circle
Crossref

Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa

Journal for ImmunoTherapy of Cancer
2022-04 | Journal article
DOI: 10.1136/jitc-2022-004601
Contributors: Yo-Ting Tsai; Julius Strauss; Nicole J Toney; Caroline Jochems; David J Venzon; James L Gulley; Jeffrey Schlom; Renee N Donahue
Source: check_circle
Crossref

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors

The Oncologist
2022-04-05 | Journal article
DOI: 10.1093/oncolo/oyac026
Contributors: Cristina Mullenix; Madison Ballman; Haobin Chen; Shannon Swift; Meredith J McAdams; Yo-Ting Tsai; Renee N Donahue; Trina Poretta; Sarthak Gupta; Patrick J Loehrer et al.
Source: check_circle
Crossref

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist
2022-03-11 | Journal article
DOI: 10.1093/oncolo/oyab046
Contributors: Jason M Redman; Yo-Ting Tsai; Benjamin A Weinberg; Renee N Donahue; Shruti Gandhy; Margaret E Gatti-Mays; Houssein Abdul Sater; Marijo Bilusic; Lisa M Cordes; Seth M Steinberg et al.
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Genome medicine. (1)
How many people are using ORCID?